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Numerous antigens are now known that can induce antibodies bearing similar or 
identical  variable region  determinants  (idiotypes)  in all individuals  of one or more 
strains of inbred mice (1-3). In many cases, the immune response to such antigens is 
of a  highly  restricted  character,  as judged  by isoelectricfocusing  (IEF) 1 of induced 
antibodies or other criteria. A curious feature is that the fraction of antibodies bearing 
a  particular cross-reactive idiotype (Id) varies markedly between the known systems. 
Characteristic  values  indicating  the  extent  of idiotypic  dominance  in  the  various 
systems can be tabulated (4). For example, ~30-35% of induced antibodies to group 
A streptococcal carbohydrate in A/J mice bear a common Id, designated A5A (5).  In 
contrast,  the response of BALB/c mice to the phosphorylcholine (PC)  determinant, 
presented on T-independent (6) or T-dependent (7) carriers, is almost entirely (>--90%) 
dominated by antibodies bearing the T15 Id. Many of the factors that determine the 
extent of dominance of a  paricular Id in a  given response are obscure, although the 
clonal  heterogeneity of B  cells capable of responding  to the epitope is likely to be 
important. 
The  enumeration  of characteristic  values  of clonal  dominance  implies  a  certain 
degree  of stability.  However,  situations  are  known  in  which  the  representation  of 
particular  Ids  changes  considerably  during  the  course  of a  response  or  during  a 
multiple  immunization  regimen.  MacDonald  and  Nisonoff (8)  reported  that  cross- 
reactive idiotypic specificities, present  in  the sera of individual  rabbits early in  the 
course  of  a  hyperimmunization  schedule  with  a  p-azobenzoate  conjugate,  were 
replaced,  at  2-4  mo,  by  a  new  set  of cross-reactive specificities.  A  better-defined 
system, the NP-b Id present on anti-(4-hydroxy-3-nitrophenyl)-acetyl (NP) antibodies 
of C57BL/6 mice, has been analyzed by M~ikel~i and Karjalainen  (9)  and Jack et al. 
(10)  and Imanishi-Kari et al. (11). Here, primary anti-NP antibodies reacted with an 
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anti-Id serum to the extent of-->85%, the proportion dropping with repeated immu- 
nization. This Change correlated with temporal alterations in IEF patterns of specific 
antibodies obtained from mice at different times during hyperimmunization. Primary 
anti-NP antibodies display four spectrotypic bands (9) common to all C57BL/6 mice. 
The patterns, however, show an increasing dominance of distinctive unshared bands 
when  individual  hyperimmunized  mice are compared.  Karjalainen  (12)  has  deter- 
mined that the expression of a different Id, NP-a in BALB/c mice responding to NP- 
chicken  gamma  globulin  (CGG),  runs  a  parallel  course  and  shows  several  other 
similarities to the NP-b system. 
Our paper deals mainly with characterization of the primary response of A/J mice 
to the antigen p-azobenzenearsonate-keyhole limpet hemocyanin  (ABA-KLH). The 
secondary and hyperimmune humoral responses of such mice include antibodies that 
bear a major cross-reactive Id (CRI), which has been extensively studied by Nisonoff 
et al. (13). The proportion of antibodies which are CRI  + from individual mice varies 
between 20 and  70%.  The mean value is in the range of 35-50%, based on indirect 
precipitation  of anti-ABA  antibodies  with  anti-CRI  (14,  15).  It has not  previously 
been clear whether  this  level of idiotypic dominance was also characteristic  of the 
primary response because, to our knowledge, this response had not been analyzed. We 
wished  to  determine  if there  was  any apparently consistent  difference in  idiotypic 
preponderance between primary, secondary, and hyperimmune responses. In addition, 
it was of interest  to compare the levels of the Id in IgM and IgG classes during the 
course of the response. Plaque-forming cell  (PFC)  methodology seemed most appro- 
priate for these purposes. We report here that an interesting trend does indeed appear: 
the  CRI  is  more  dominant  in  the  primary  than  in  secondary  or  hyperimmune 
responses, and thus resembles the NP-b and NP-a systems in that respect. Furthermore, 
the  kinetics  of the  primary response were  consistent  with  the  idea  that  IgG PFC 
originate from IgM PFC by isotype switching.  However, it appeared that there was 
a elonal preference in the switching step, and that CRI  + IgM PFC were preferentially 
switched to give rise to a striking Id dominance in early IgG PFC. 
Materials and Methods 
Mice.  Female A/J mice were obtained from The Jackson Laboratory, Bar Harbor, Maine 
and used at age 6-16 wk. 
Antigens and Immunizations.  ABA-KLH was prepared by dissolving  2 g KLH (Calbiochem- 
Behring Corp., American Hoeehst Corp., San Diego,  Calif.)  in 50 ml borate-buffered saline 
(16), pH 9.1.2 mmol ofABA diazonium salt in solution was added, with stirring, over a 15-min 
period while the pH was maintained at 9.1  with 4 N  NaOH. The reaction was allowed to 
proceed on ice for 2 h, followed by dialysis against phosphate-buffered saline (PBS) and storage 
at -20°C. The ABA diazonium salt solution was prepared by dissolving  2 mmol (434 mg) p- 
arsanilic acid (Eastman Kodak Co., Rochester, N. Y.) in 6 ml of 1 N HC1 at 0°C, followed by 
addition of 2 ml of 1 M NaNO2 in saline in three aliquots over a 3-min period, and then 2 ml 
of H~O at 0°C.  ABA was coupled to CGG and  human  myeloma protein according to the 
method of Tabachnick and Sobotka (17). Trinitrophenylated CGG (TNP-CGG) and TNP- 
sheep erythrocytes (SRC)  were prepared according to the method of Garvey et al. (16). 
Conjugates were typically dissolved in PBS to 10 mg/ml or 5 mg/ml, emulsified in an equal 
volume of complete Difco adjuvant H37 Ra (CDA), and administered i.p. in 0.1- or 0.2-ml vol, 
as given elsewhere. 
Anti-CRI Sera.  Rabbit anti-CRI sera were produced according to the method of Ju et al. 
(18) by repeated immunization of rabbits with affinity-purified A/J anti-ABA antibodies from 
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4B  coupled with  normal A/J Ig [(NI-h)2SO4-precipitated proteins from  A/J hyperimmune 
ascites induced by CDA alone]. Anti-CRI sera were judged to be Id specific by an enzyme- 
linked immunosorbent assay (ELISA) (19) analysis: the antisera that bound to CRI that was 
adsorbed to plastic microtiter dish wells was detected with protein A  coupled with alkaline 
phosphatase. Binding was inhibited _>94% in the presence of excess free CRI but not >10-15% 
by excess normal A/J Ig. A specificity analysis of the anti-CRI sera was also performed in the 
plaque assay (Results). 
Hemolytic Plaque Assay.  ABA was conjugated to SRC via an intermediate imidoester linkage 
as described by Isakson et al. (20).  In this protocol, p-arsanilic acid was first diazotized and 
coupled to  methyl p-hydroxybenzimidate (HB)  (Pierce Chemical Co.,  Rockford, Ill.). The 
resulting compound was then reacted overnight with SRC. The ABA-HB-SRC prepared this 
way were  shown  in  preliminary assays to  disclose 5-10  times as many  PFC  as ABA-SRC 
prepared by direct diazotization. 
A modification of the original Jerne plaque assay (21) was employed in these studies. A 0.5% 
solution of Bacto-Agar (Difco Laboratories, Detroit, Mich.)  in Earle's balanced salt solution 
(EBSS),  containing 400  #g/ml  DEAE-dextran  (Sigma Chemical  Co.,  St.  Louis, Mo.),  was 
prepared and distributed in 0.5-ml aliquots into small tubes in a 46°(2: water bath. 50 #1 of a 
1:4 suspension of ABA-HB-SRC in PBS was then added along with  100 #1 of washed splenic 
lymphocytes at an appropriate dilution in EBSS (to give 100-800  PFC/plate).  10 #1 of goat 
anti-mouse IgM (N. L. Cappel Laboratories Inc., Cochranville, Pa.) was also added to some 
tubes for indirect PFC determination (i.e., to inhibit IgM PFC). For analysis of CRI content of 
PFC, 6-10 #1 of rabbit anti-CRI was added to some tubes. Each mixture was then  gently 
vortexed and spread in a circular motion on the surface of a  plastic 13- ×  100-mm petri dish 
(1001;  Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) to cover about two- 
thirds of the area, allowed to harden, and then incubated in a humid box at 37°C for 1 h. 2 ml 
of a  1:40 dilution of guinea pig complement (C)  (Grand Island Biological Co., Grand Island, 
N. Y.) in cold EBSS was then layered over the agar. To develop IgG plaques, rabbit anti-mouse 
IgG (N. L. Cappel Laboratories Inc.) was added to the C  solution at an appropriate dilution 
for optimal indirect PFC development (1:200-1:800). No indirect plaques developed without 
addition of this antiserum. Dishes were then further incubated for 2 h  at 37°C,  followed by 
counting of PFC. 
The formula for the percent CRI  + PFC used was: [1 -  PFC (with anti-CRI)/PFC (without 
anti-CRI)] ×  100% =  the percent CRI  + PFC. Nonspecific PFC, as determined by plaquing 
against unconjugated SRC, were always subtracted beforehand. 
Hapten Inhibition of PFC.  ABA-g-tyrosine (RAT) was prepared as described previously (22) 
and dissolved in EBSS in half-log concentration intervals. 3 ml of the indicated concentration 
of hapten solution was overlayed on the agar immediately after hardening in individual petri 
plates. After 1 h  incubation at  37°C,  guinea pig C  and rabbit anti-mouse IgG were added 
directly to the hapten solution followed by 2 h of further incubation. EBSS alone was overlayed 
on control plates. 
Hybridoma AK-2.2.  The  hybridoma used  in  the  hapten  inhibition studies was  prepared 
according to the method of Oi and Herzenberg (23) by fusing NS-1 myeloma cells with spleen 
cells from  an A/J mouse hyperimmunized with ABA-KLH. The spleen donor was given a 
single intravenous boost of 50 #g ABA-KLH 4 d before fusion. Hybridoma AK-2.2 (IgG,K) was 
selected with hypoxanthine-arninopterin-thymidine  medium, cloned twice by limiting-dilution, 
and grown in Dulbecco's modified Eagle's medium (DME) H21  with 10% fetal calf serum. It 
was CRI  + by anti-CRI inhibition of PFC. 
Statistical Analysis.  The difference in levels of CRI in IgM and IgG PFC was compared for 
significance using the Student's t test for paired samples (24). 
Results 
Specificity and Titration  of Anti-CRI.  Analysis of the specificity of anti-CRI sera by 
ELISA has been described in Materials and Methods. Specificity was also checked in 
the plaque assay, and titrations were performed to determine the optimal quantity of 
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primary and secondary PFC, is shown in Fig. 1. The titration results are essentially as 
expected. Inhibition of PFC  increases to a  plateau  level with  increasing anti-CRI. 
The plateau is typically not entirely flat, but shows a slight upward slope, probably 
a  result of nonspecific inhibitory activity of the antiserum. Because it was observed 
that some normal rabbit sera could inhibit plaques at >10 #1 per plate, only those 
anti-CRI giving maximal inhibition at _<10 #l were used. Based on these results, 3c 
was routinely used at 10 #1 per plate. At this concentration, 3c caused little inhibition 
of A/] primary anti-TNP and secondary anti-SRC PFC (Fig.  1). Another anti-CRI 
serum used in some of the experiments given here, IIb, gave similar satisfactory results 
(data not shown) and was used at 6 #1 per plate. 
Also shown  in  Fig.  1 A  is a  titration with a  rabbit antiserum prepared against  a 
CRI  + hybridoma antibody, R16.7 (25), kindly supplied by Dr. A. Nisonoff, Brandeis 
University, Waltham, Mass. This antiserum gave substantial and almost equivalent 
inhibition  of the  direct  and  indirect  primary  PFC.  CRI  +  IgM  PFC  are  readily 
detectable in both the A/J response to ABA-KLH and to the T  independent antigen, 
ABA-Brucella abortus (26). 
Kinetics of the  A/J  Prima~y Response to  ABA-KLH.  The  kinetics  of the  primary 
response of A/J mice to a single injection of 500/~g ABA-KLH, in terms of total PFC 
per spleen  and  CRI  + proportion of these, are shown  in  Fig.  2.  The results of two 
separate experiments are given. Some of the differences between the two studies may 
be attributable to differences in immunization protocol (see legend to Fig. 2). In spite 
of this, some interesting points of concordance are apparent. 
First,  the  IgM  PFC  show a  biphasic  course.  Such oscillatory kinetics have been 
reported in other responses to different antigens  (27,  28). The situation with respect 
to IgG PFC  is  less  certain  (compare Fig.  2,  studies  1 A  and  2A).  Both  direct and 
indirect  PFC  per spleen  are  low  on  day  18  (Table I,  line 2)  and  peaks were not 
detected after day 13. 
A second point of particular interest is the very high dominance of the CRI in both 
the  IgM  and  IgG PFC  populations which surpass  80% CRI  ÷  in  the course of the 
primary response (Fig. 2). This finding did not correlate well with previously reported 
lower values for hyperimmune antibodies (14, 15), and there existed some uncertainty 
--  3C  •  Direct  PFC 
....  anti-RI6.7  o  Indirect  PFC 
I00 I~-  A  B 
g  ...... ~.---- 
40  o  o-'"" 
t  I  J  l  l  I  I  I 
2  6  I0  14  2  6  I0  14 
onti-CRl  added  (juL] 
Fro.  I.  An  example of a  specificity  and  tiration  analysis of two  anti-CRI  sera. Two  A/J  mice 
received a  single injection each of 500 ~g ABA-KLH in CDA and were plaqued  12 d  later  (A). 
Control  mice  (triangles)  were  injected  with  100/.tg TNP-CGG  and plaqued  against TNP-SRC. 
Alternatively, mice received a priming injection and were boosted 5 wk later and plaqued at day 10 
postchallenge (B). Control mice (squares) were undergoing a  secondary anti-SRC response. Two 
anti-CRI sera were checked with  primary PFC:  3c, a  rabbit  antiserum to pooled  A/J anti-ABA 
antibodies;  and anti-R16.7,  a  rabbit  antiserum to a  CRI  +  hybridoma antibody  (see text).  Solid 
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FIG.  2.  Two kinetic studies (1 A and B; 2 A and B) of the primary responses of A/J mice to ABA- 
KLH. (0) direct PFC; (O)  indirect PFC. A large group of mice received a single injection each of 
500 pg ABA-KLH in PBS and emulsified 1:1  in CDA in a  total vol of 0.1  ml (study I) or 0.2 ml 
(study 2) on day 0. Mean values for four mice (study 1) or three mice (study 2) per day are given. 
IgG PFC are shown beginning on their first day of appearance. A  number of control mice were 
injected with 500/~g KLH in CDA and checked for anti-ABA PFC; no more than 700 PFC/spleen 
were ever detected. In studies 1 A and 2A, geometric mean PFC/spleen are given; SE limits are 
omitted for clarity. Mean SEM for study 1A =  1.33; for study 2A =  1.28 (geometric mean X/+  1 
SEM). In studies 1 B and 2 B, arithmetic mean of the percent CRI  + PFC +  1 SEM is indicated. 
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TABLE  I 
PFC and Id Profile at  Various Times in Anti-ABA Responses 
Immunization protocol 
Day§ 
PFC/spleen* 
Prime:~  Challenge  Direct  CRI +  Indirect  CRI  + 
3  A-K 
4  A-K 
5  A-K¶ 
6 
7  A-CGG 
%  % 
A-KII  10  29,823(1.31)  55  46,838(1.30)  87 
A-K  18  2,043(1.22)  30  3,247(1.28)  56 
A-K  3  7,735(1.13)  68  27,752(1.22)  36 
A-K  10  249,319(1.37)  64  423,185(1.24)  34 
A-K (PBS)  10  124,590(1.73)  70  217,262(1.18)  39 
A-CGG  10  2,607(1.11)  60  5,063(1.06)  72 
A-CGG  10  105,342(1.48)  55  439,880(1.35)  41 
* Data presented as geometric mean ×/+  SEM. All results are pooled from two or more experiments: 
:~ 500 #g antigen (ABA-KLH [A-K]) in CDA injected i.p. Challenge was 5 wk after priming. 
§ Po~tchallenge. 
II From Fig. 2, studies 1 A and 2 A. 
¶ Hyperimmunized, five or more injections. 1178  IDIOTYPIC DOMINANCE IN A  PRIMARY  RESPONSE 
as to whether the difference was a result of the differing methodologies employed. To 
investigate this point, a group of A/J mice that had been hyperimmunized with ABA- 
KLH in CDA  (five or more injections) was boosted with 50 #g ABA-KLH in PBS 
and ~plaqued 7 d  later. The results (Table I, line 5) showed an approximate four- to 
fivefold increase in direct and indirect PFC over the primary response. More impor- 
tantly,  the  IgG  PFC  were only  39%  CRI  +.  IgM  PFC  showed  a  much  higher Id 
content-- ~70%.  If analyzed serologically, the overall CRI  + percentage would un- 
doubtedly  be  dictated  mainly  by  the  larger  quantity  of IgG  present.  A  clearcut 
idiotypic maturation had thus occured in the IgG PFC population and this resulted 
in  good  agreement  between  the  present  and  previous data  (14,  15).  It  should  be 
pointed out (Table I, line 4) that animals undergoing a secondary response, induced 
5 wk after an initial injection of ABA-KLH with the same antigen and checked on 
day 10, showed an Id profile like that of hyperimmune animals (IgG PFC only 34% 
CRI+). It thus seemed likely that the extreme Id dominance in the primary response 
was real. 
A  third point worthy of note in the kinetic data is that  the Id dominance of the 
CRI does not appear to be quantitatively equal between IgM and IgG PFC, even for 
the  earliest-appearing  IgG  PFC.  A  statistical  analysis  of IgM  and  IgG  PFC  in 
individual mice on the first day of appearance of IgG PFC (day 8 in study 1 and day 
6 in study 2 of Fig. 2) showed that IgG PFC were significantly higher than IgM PFC 
in terms of proportion of CRI  + PFC  (P <  0.025 in study 1; P  <  0.001  in study 2 of 
Fig. 2). This is strikingly illustrated on day 6, Fig.  2B, where  100% of the IgG PFC 
were CRI  ÷, whereas the mean for IgM PFC was only ~60%. This result, with earliest 
IgG PFC being  100% CRI  +, was also seen in another study (data not shown). The 
first indirect PFC in study 1 were only 76% CRI  +. However, this value increased to 
90% by day  13, i.e., a  slow, steady increase occurred. During this time, though, the 
IgM PFC decreased steadily in terms of CRI content from 62 to <30%  (Fig.  1 B). A 
mechanism that could explain this data is that CRI  + IgM PFC were being preferen- 
tially switched to CRI  + IgG PFC. 
Other  Time Points and Different  Carriers.  After peaking on day  10, both direct and 
indirect PFC declined steadily as indicated by the data for day  18 of the primary 
response  (Table I, line 2).  The percentage of IgG PFC which were CRI  + also had 
dropped from a peak of 80-100% to only 56%. It was of interest to determine whether 
the Id made a  transient recovery in early secondary IgG PFC. This apparently was 
not the case because the Id profile at day 3 already resembled that at day 10 in the 
secondary or hyperimmune responses, i.e., IgG PFC at 30-40% CRI  + with IgM PFC 
higher at ~70% CRI + (Table I, line 3). 
The carrier protein KLH, coupled with ABA, was not unique in inducing a strong 
Id  dominance  in  the  primary  response.  ABA-CGG  gave  a  comparable  pattern 
including the idiotypic maturation of IgG PFC (Table I, lines 6 and  7). The clonal 
dominance does not appear as great in this case, but a complete kinetic analysis was 
not done and so this may not represent the CRI peak. Another T  dependent antigen, 
ABA  coupled  to  a  human  myeloma protein,  and  administered  in  CDA,  did  not 
induce a detectable primary response. 
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FIo. 3.  Data derived by hapten  inhibition of indirect PFC. Primary IgG PFC were checked on 
day l0 after an i.p. injection of 500/~g ABA-KLH and secondary IgG PFC on the same day after 
a boost of 500 ~g ABA-KLH which was 5 wk after priming (same quantity of the same antigen). 
Results for six spleens are pooled per point. Plaquing was as described in the Materials and Methods 
section, except that the agar was overlayed with 3 ml of inhibitor (RAT in EBSS) of the indicated 
concentration. AK-2.2 are hybridoma cells secreting IgG anti-ABA antibodies (CRI+ by anti-CRI 
inhibition). The single open circle at 10  -s M RAT indicates the absence of inhibition of secondary 
anti-SRC PFC. Median association constant (K) was calculated using the formula K = 2/H50 (19). 
of PFC with  free hapten  can provide estimates  of avidity and  heterogeneity  at  the 
cellular level  (29, 30). This technique was used to determine if the primary response 
represents a more restricted population of antibody-secreting cells than the secondary 
response,  as suggested  by anti-Id inhibition.  Relative  heterogeneity  in these experi- 
ments  was  based  on  the  slope  of the  inhibition  line  between  H75  and  H~  (molar 
concentration of inhibitor causing  75% and  25%  inhibition  of PFC, respectively).  It 
can be seen that the data points describe a  nearly straight line in this region with the 
primary response giving a  steeper slope (lower H75/H25)  than the secondary response 
(Fig. 3). For purposes of comparison, and also to verify that this method probably was 
detecting avidity distribution, AK-2.2 hybridoma cells, secreting IgG anti-ABA, were 
plaqued. This hybridoma was derived by fusion of A/J anti-ABA-KLH hyperimmune 
spleen  cells  and  NS-1  myeloma  cells,  and  is  CRI  +  by  anti-Id  inhibition  of PFC, 
although  it  has  not  unequivocally  been  shown  to  express  the  major  idiotope(s) 
associated with the CRI. A  steep slope was obtained with Hvs/Hz5 equal to 2.7. The 
data thus suggest that primary IgG PFC approach a monoclonal population in terms 
of avidity distribution,  with secondary PFC being considerably more heterogeneous. 
The  data  are  also  informative  as  to  avidity  changes.  Using  the  simple  relation 
worked  out  by  Jerne  et  al.  (21),  K  =  2/H50,  where  K  is  the  median  association 
constant, the values given in Fig. 3 were obtained.  The results suggest that a  10-fold 
increase in avidity occurred between the primary and the secondary response in IgG 
PFC. (IgM PFC were not tested by this method because a very high concentration of 
free  hapten  was  required  to  give  any  inhibition.)  The  association  constant  for 
secondary PFC  which was  derived  here  is surprisingly  close to that  determined  by 
Kapsalis et al. (31) for the ABA system, using hyperimmune antibodies and essentially 
the same ligand,  RAT, in equilibrium  dialysis.  Because the primary PFC were 88% 1180  IDIOTYPIC DOMINANCE IN  A  PRIMARY  RESPONSE 
CRI  + whereas  the secondary were only 36%  CRI  +,  idiotypic maturation  occurred 
concurrently with avidity maturation in this PFC population, but  they showed an 
inverse correlation (CRI declined with increasing avidity). 
Discussion 
The A/J  CRI  is  one of the best  characterized of the CRI  systems.  Studies that 
utilized mainly radioimmune competition assays, with affinity-purified hyperimmune 
serum or ascitic anti-ABA antibodies, have revealed numerous interesting features 
(13).  The CRI shows  genetic linkage to heavy chain constant region  (CH)  allotype 
(32)  and also to an Ly-3 polymorphism which is closely linked to the K light chain 
locus (33). It is found on 20-70% of hyperimmune anti-ABA antibodies in individual 
mice and  is  associated mostly with  the  IgG1 class.  On  IEF, bands with  isoelectric 
points (pI) of 6.7 and 6.9 were highly enriched for the Id. Analysis of serum antibodies 
suggested a single heavy chain variable region (VH) sequence in CRI  + molecules (34). 
More recent analysis of CRI  + hybridoma antibodies, however, demonstrated consid- 
erable heterogeneity, both in the light chain variable region  (VL) and VH (35, 36). 
CRI  + hybridomas that secrete IgM or any of the subclasses of IgG have now been 
reported (25), and serological studies revealed both cross-reactive (public) and indi- 
vidual  (private)  Id determinants on many of them  (25,  36).  It is likely that  serum 
antibodies also express this heterogeneity (37). 
The present studies were undertaken to characterize the primary response of A/J 
mice to ABA-KLH, which was not detected in earlier studies  (38). Current success 
may be a  result, at least  in part, of the use of the more sensitive ABA imidoester- 
coupled SRC (20)  instead of the directly diazo-coupled indicator cells used formerly 
in  the  plaque  assay.  However, the  possibility  has  not  been  ruled  ou~  that  minor 
variations in properties of the antigen preparation, such as extent of ABA substitution 
or degree of aggregation of the KLH, might dramatically influence the outcome of a 
primary immunization.  Such minor variations may be of particular importance in 
responses dominated by a  major Id.  In  support  of this are the results reported by 
Claflin et al. (39) that PC-KLH induced a fairly weak, exclusively IgM PFC response 
in BALB/c mice, even after repeated immunizations. In contrast, Bottomly et al. (7), 
using the same mouse strain and antigen in adoptive-transfer experiments, obtained 
much stronger responses, which included IgG PFC. 
We used PFC methodology throughout these experiments, with inhibition by anti- 
CRI to determine the proportion of plaques which were CRI  +. It was important first 
to titrate the anti-Id to ensure that inhibition was on a plateau level for both primary 
and secondary PFC (Fig.  1). Thus, all CRI + PFC should have been detected and the 
differences in Id content which were observed were not likely a  result of changes in 
other properties, such as secretion rate. Inhibition with an antiserum prepared against 
a  CRI  + hybridoma antibody, R16.7,  was also checked with primary PFC.  It  gave 
inhibition of both IgM and IgG PFC comparable with that obtained with the rabbit 
anti-CRI.  Although  this result seems surprising,  it should be noted that  R16.7  has 
somewhat unusual properties compared with other CRI  + hybridoma antibodies (25): 
it  inhibits  the  binding  of rabbit  anti-CRI  to  labeled  CRI  (pooled A/J  anti-ABA 
antibodies) almost as well as does unlabeled CRI, and in excess causes almost  100% 
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fractional degrees of inhibition (25). On the basis of these observations, it has been 
suggested (25) that pooled A/J anti-ABA antibody may contain multiple distinct CRI 
determinants, and that R16.7 may carry most of these on a single molecule. If so, it 
might be expected that rabbit anti-CIRI and anti-R 16.7 would have similar inhibitory 
properties. 
Our  data  disclose  a  regular  pattern  of temporal  variation  in  CRI  dominance 
between the primary and the secondary or hyperimmune responses of A/J mice to the 
ABA epitope. As in the NP-a and NP-b systems (9, 12), the major Id is more dominant 
in the early than in the later responses, at ~east among IgG PFCI. A day-by-day kinetic 
analysis of Id dominance in the primary response and at selected time points in the 
secondary and hyperimmune responses revealed the following scenario. At day 3 in 
the primary response, IgM PFC were 40-60% CRI + and this percentage increased to 
70-85% by day 7. From then until day 11 or 13, the CRI content of IgM PFC either 
remained fairly stable at this level or decreased sharply to -30%, depending on the 
immunization protocol. IgG PFCI first appeared at day 6 or 8 and were significantly 
higher in CRI  + proportion than  IgM  PFC on that  day.  From a  peak of 85-100% 
CRI  +,  IgG PFC  had  declined  to 50-60%  CRI  + by day  18.  Although  increased  in 
numbers,  IgG  PFC  were  only  30-40%  CRI  +  in  the  secondary  (day  3  or  10)  or 
hyperimmune (day 10) responses. This idiotypic maturation in indirect PFC correlated 
inversely with an approximate 10-fold increase in median binding avidity. 
The same type of idiotypic maturation found here, and known to occur with NP-b 
and NP-a, may be characteristic of some other systems as well. For example, BALB/ 
c mice respond to the T-independent antigen bacterial levan (BL) with production of 
inulin-binding  antibodies, the great  majority of which bear an  Id shared with  the 
U61 myeloma protein (40). No apparent maturation of this response is seen, by IEF 
analysis, on repeated immunization with BL (41). However, antibodies produced by 
mice  in  response to  inulin-KLH clearly become more heterogenous after multiple 
immunizations  (see  Fig.  3  of  [41]);  primary,  but  not  secondary  antibodies,  are 
dominated by five invariant shared bands. An Id analysis might show that U61 Id is 
similar to CRI, NP-b, and NP-a with respect to the dynamics of Id dominance during 
the course of the response. Many other Id, however, are unlikely to fall in the same 
category. As one example, it was reported recently (42)  that  a  major Id present on 
murine antibodies to hen egg-white lysozyme from hyperimmune animals was  not 
present on primary antibodies to the same antigen. Furthermore, whereas the simi- 
larity of the CRI and NP-b systems has been stressed, the two are likely to show some 
major differences. In particular, the ~ to r  light chain shift seen with NP-b (9) is not 
likely to occur in the CRI system, because the latter is dependent on r  chains for its 
expression (33), at least on antibodies. 
The hapten-inhibition data tend to support conclusions derivable from the anti-Id 
analysis concerning relative heterogeneity of primary and secondary PFC responses. 
They also indicate that secondary IgG PFC show a median avidity which is -  lO-fold 
higher than that of primary IgG PFC. Although the association constant calculated 
for secondary IgG PFCI agreed quite well with that  derived by Kapsalis et al.  (31) 
who  used  equilibrium  dialysis,  the  comparative  data  introduce  a  problem.  They 
reported that the avidity of CRI  + antibodies in the hyperimmune response was only 
slightly less  than the mean avidity of hyperimmune antibodies in general, whereas 
the data in Fig. 3 indicate that primary IgG PFC, which are almost entirely CRI  +, 1182  IDIOTYPIC DOMINANCE IN A PRIMARY RESPONSE 
have  a  median  avidity  10  times  lower  than  secondary  PFC.  To  reconcile  these 
observations, one would have to postulate that avidity maturation occured within the 
CRI  +  population,  and  this  would  require a  heterogeneity of binding  sites  in  that 
population.  Such  a  postulate  is  tenable  in  view  of  the  evidence  for  structural 
heterogeneity of CRI  + molecules mentioned earlier, but our findings are inconclusive 
inasmuch  as  the  CRI-  population  in  hyperimmune  sera  could  account  for  the 
observed  avidity  differences.  Moreover,  because  objections  to  the  use  of hapten 
inhibition of PFC for avidity estimates have been raised on both theoretical (43) and 
practical  (44)  grounds,  it  would  be  necessary  to  directly  compare  primary  and 
secondary antibodies by equilibrium dialysis before reaching any firm conclusions. 
One of the most interesting findings in our studies was the difference in dominance 
of the Id in IgM and IgG classes. Except for the period in the primary response when 
substantial numbers of IgM PFC were presumably switching to IgG, the fraction of 
CRI  ÷ IgM PFC remained high.  In contrast, the proportion of Id  + PFC of the IgG 
class  decreased  considerably  after  peaking  in  the  early  primary  response.  It  is 
noteworthy that this course of events parallels that which has been observed elsewhere 
in  several  studies  of avidity  maturation  (45,  46):  a  clearcut  avidity  maturation 
(increase) in IgG but little, if any, in IgM.  Assuming that  both IgM and IgG PFC 
populations express comparable variable (V)-region diversity, the mechanisms, cur- 
rently unknown, for the differential avidity maturation  (if such is indeed occurring 
here)  may  be  equivalent  to  those  responsible  for  the  differential  Id  maturation, 
especially if these have a cause-and-effect relationship. That is, low-avidity CRI  + PFC 
may be eclipsed, in the course of the response, because of the more rapid expansion 
of higher-avidity CRI- PFC among IgG, but not IgM, PFC. Although some avidity 
maturation might occur within the CRI  + population, this may be more limited than 
that possible in the Id- population. One would predict, on this basis, that major Id 
that have no avidity advantage, such as the anti-ABA CRI, would peak early in the 
response, whereas Id with high avidity for antigen might become increasingly domi- 
nant as the response progresses. A late-appearing Id has recently been described (42), 
but  no  avidity  data  are  available  as  yet.  As  an  alternative  to  a  purely  selective 
mechanism, one might postulate that IgG PFC contain more V-region diversity than 
IgM PFC, which would require somatic generation of diversity during or after the 
isotype switch.  Although  such  a  mechanism  would readily explain  the differential 
maturation phenomena, there is no solid evidence to support it. 
The kinetic data on the primary response suggest that a preferential isotype switch, 
based on idiotype, is effected, and this raises the question of T  cell involvement. The 
role ofT ceils in promoting the IgM to IgG shift is still controversial, but the following 
two points seem well established: T  cells may not be absolutely required for inducing 
the switch in at least some B cells, because this shift has been observed in cultures of 
"purified" B cells activated by lipopolysaccharide (47, 48). However, T  cells can at 
least greatly facilitate the switch (49). The theory that we currently favor for the high 
Id dominance in the primary response, as well as the preferential switching, is that 
CRI  + IgM-secreting B cells receive more T  cell help than CRI- ones, and, thus, they 
differentiate faster. The extra help might derive from an Id-specific T  helper (Th) cell 
for which  we  have  preliminary  evidence  (our unpublished  data).  There is  ample 
evidence, in  several systems,  for the  existence of naturally occurring Th ceils that 
recognize autologous immunoglobulin  determinants,  including  idiotypic ones  (50). JOHN D. CONGER, GEORGE K. LEWIS, AND JOEL W. GOODMAN  1183 
Woodland and Cantor (51)  have already demonstrated the requirement, in the A/J 
CRI  system,  for an  Id-specific,  CRI  complementary Th  cell  to  activate  CRI  +  B 
memory cells in  adoptive secondary responses.  This same cell may be causing the 
effects described here in the primary response. However, the possibility has not been 
excluded that  anti-ABA B  cell precursors in unprimed A/J mice might be mainly 
CRI  +, thus accounting for the Id dominance in the primary response, but  not the 
selective isotype switching. These questions are currently being investigated. 
Summary 
The primary response of A/J mice to p-azobenzenearsonate-keyhole limpet hemo- 
eyanin (ABA-KLH) was investigated. A  day-by-day analysis at the plaque-forming 
cell (PFC) level was performed, with inhibition by anti-cross-reactive idiotype (CRI) 
serum to determine percentage of CRI  + PFC. A regular pattern in the dynamics of Id 
(idiotype) dominance was observed. Just as in the NP-b and NP-a systems (9,  12), the 
major Id  (CRI)  is  more dominant  in primary than  in secondary or hyperimmune 
responses. This trend is more apparent in IgG PFC which are generally 80-95% CRI  + 
at day 10 in the primary response but only 30-40% CRI  + at day 10 in secondary or 
hyperimmune responses. A somewhat different pattern is seen with IgM PFC. These 
may reach a  peak of 85% CRI  + in the primary response, but secondary or hyperim- 
mune IgM PFC, which are lower in numbers than  IgG PFC,  remain high in CRI 
content at  -70%. The PFC data on extent of id dominance in secondary or hyper- 
immune responses is  fully compatible with previously reported serological data by 
others. Analysis of IgG PFC by hapten inhibition indicated that heterogeneity was in 
the order secondary PFC >  primary PFC >  hybridoma AK-2.2 PFC with HTs/Hz~ 
values of 22.9, 6.2, and 2.7, respectively; where HTs and H25 are the hapten concen- 
trations required  to give 75%  and  25% of inhibition of PFC,  respectively. Hapten 
inhibition  data  also  suggested  that  secondary IgG  PFC  were  10  times  higher  in 
median binding avidity for ABA-L-tyrosine than primary IgG PFC. 
The kinetic analysis strongly indicated  that  CRI  +  IgM  PFC were preferentially 
switched to IgG PFC in the primary response. In both studies, the CRI content of the 
earliest-appearing IgG PFC was significantly higher than that of IgM PFC on that 
day. For example, in one case IgM PFC were 60% CRI  + on day 6 whereas IgG PFC 
were 100% CRI  +. The high Id dominance and selective isotype switching may have 
either a B or a T  cell basis. 
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